LamdaGen has developed a highly sensitive Diagnostic Cardiac Troponin I (cTnI) assay. The Troponin I assay is based upon LamdaGen’s patented Plasmonic ELISA method known as the Optical Enhancement System™ (OES™).
This ultra-sensitive cTnI Plasmonic ELISA utilizes a sandwich immunoassay-coupled with the company’s Localized Surface Plasmon Resonance (LSPR) technology to precisely quantitate the concentration of cTnI in human whole blood, plasma and serum specimens into the sub-picogram range.
Go to Application Note
LamdaGen’s LightPath™ Systems and Sensors enable characterization of biomolecular, enzymatic and chemical type reactions in real-time